J DRUGS DERMATOL 潤色咨詢

Journal of Drugs in Dermatology

出版年份:2002 年文章數(shù):2346 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Monthly 自引率:10.8% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量暫無數(shù)據(jù) (2022年為0.00%)
自引率
10.8 %
年文章數(shù)
2346
期刊官網(wǎng)
點擊查看 (點擊次數(shù):1942)
投稿鏈接
點擊查看 (點擊次數(shù):784次)
作者需知
點擊查看 (點擊次數(shù):2098次)
偏重的研究方向
暫無數(shù)據(jù)
期刊簡介
稿件收錄要求

ISSN: 1545-9616.

The?Journal of Drugs in Dermatology?(JDD) is a peer-reviewed publication indexed with MEDLINE?/PubMed? that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.

JDD reaches around 13,760 dermatology healthcare professionals and has been recognized as the official partner of the?International Society of Dermatologic Surgery (ISDS),?Skin of Color Update (SOCU), and the?ODAC Dermatology Aesthetic and Surgical (ODAC) conferences.

The extremely current and practical editorial content of JDD results in high readership and maximum exposure among the dermatology community.

Our Mission is Excellence through Peer Review: To educate physicians, optimize patient outcomes, and disseminate key scientific information.

JDD is published by?SanovaWorks.